Figure 3From: Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia Probabilistic cost-effectiveness plane in which the LYG are plotted versus the costs for PCV13 and PCV10 in a cohort of Colombian newborns, 2014. Back to article page